Board of Directors

Wenche Rolfsen
Wenche Rolfsen
Chairman of the Board

Born: 1952

Other assignments: Chairman of InDex Pharmaceuticals Holding AB. Board member of  InDex Diagnostics AB; CEO and Board member of Rolfsen Consulting AB. Partner in Serendipity Partners.

Education: Pharmacist, Doctor of Pharmacy (pharma-cognosy), Adjunct Professor at Uppsala University, Sweden

Experience and prior assignments: Head of pharmacology at Pharmacia & Upjohn; VP clinical trials Quintiles Europe, CEO of Quintiles Scandinavia. Chairman of Aprea Therapeutics AB, Denator AB and Aprea Personal AB. Board member of SOBI AB, Recipharm AB, Smartfish AB, Moberg Pharma AB, TFS Trial Form Support Internatio-nal AB, Apotek Produktion & Laboratorier AB and Industrifonden.

Board member since: 2016

Independent in relation to the company, its senior management and major shareholders.

Total holdings* in BioArctic: 49,175 Class B shares

Ivar Verner
Ivar Verner
Vice Chairman and Board member

Born: 1947

Other assignments: Chairman of Erlandsons Brygga AB, Centrum Fastigheter i Norrtalje AB, Tegner & Son AB and Valsattra Exploaterings AB. Board member of Sehlhall Fastigheter AB.

Education: Master of Business Administration, Stockholm School of Economics, Sweden.

Experience and prior assignments: Chairman of Rejlers AB, Welcome Hotel i Sverige AB, Constrera AB and Grant Thornton Sweden AB. Board member of Forex Bank AB and Svenska Vardfastigheter AB.

Board member since: 2010.

Member of Committee: Chairman of the Audit Committee.

Independent in relation to the company, its senior management and major shareholders.

Total holdings* in BioArctic: 113,770 Class B shares, privately and through Förvaltningsaktiebolaget Kanalen AB.

Håkan Englund
Håkan Englund
Board member

Born: 1952

Other assignments: Chairman of the Board of SecureAppbox AB. Board member of Antrad Medical AB, Immuneed AB and Chundsell Medicals AB. Owner and CEO of JDS Invest AB. Company involved in business consulting and private placements in both private and public companies.

Education: Various courses in economics and chemistry from Uppsala University, Sweden. Courses in polymer technology at Royal Institute of Technology in Stockholm, Sweden.

Experience and prior assignments: Various management positions, including commercial leadership roles, at Pharmacia Biotech AB and Phadia AB with over 30 years of experience in the industry. Previous board director at Apotekssamariten AB, Olink AB, Sensidose AB and Arocell AB.

Board member since: 2020.

Independent in relation to the company, its senior management and major shareholders.

Total holdings* in BioArctic: 0 shares.

Pär Gellerfors
Pär Gellerfors
Board member

Born: 1947

Other assignments: CEO and Board member of Swenora Biotech AB. Board member of Ackelsta AB, LPB Sweden AB and Sigrid Therapeutics AB.

Education: Bachelor degree in chemistry; PhD in chemistry; Associate Professor of Biochemistry. All at Stockholm University, Sweden.

Experience and prior assignments: CEO and board member of SpineMedical Sverige AB and SpineMedical AB. Board member of LPB Sweden Holding AB.

Board member since: 2003

Independent in relation to the company and its senior management. Dependent in relation to major shareholders.

Total holdings* in BioArctic: 5,759,988 Class A shares through Ackelsta AB and 13,343,201 Class B shares through Ackelsta AB.

Lars Lannfelt
Lars Lannfelt
Board member

Born: 1949

Other assignments: Board member of Demban AB and LPB Sweden AB.

Education: Medical degree (specialist in psychiatry) and doctoral thesis at Karolinska Institutet, Stockholm, Sweden; Associate Professor of Neurogenetics at Karolinska Institutet, specialist in geriatrics.

Experience and prior assignments: Professor of Geriatrics at Uppsala University; Senior Professor at Uppsala University and member of the Royal Swedish Academy of Sciences. Founder of BioArctic in 2003, Chairman of the Board and a number of assignments and roles in the company.

Board member since: 2023

Dependent in relation to the company, its senior management and major shareholders.

Total holdings* in BioArctic: 8,639,998 Class A shares through Demban AB. 20,885,052 Class B shares through Demban AB.

Lotta Ljungqvist
Lotta Ljungqvist
Board member

Born: 1961

Other assignments: CEO of Testa Center, Cytiva (formerly GE Healthcare Life Sciences). Board member of Atlas Antibodies AB, Genovis AB and Arocell AB. Chairperson of the Biotechnology division at the Royal Swedish Academy of Engineering Sciences (IVA) and Chairperson at SwedenBio as well as member of the Board of Vinnova and SciLifeLab.

Education: Degree in biochemistry from the Royal Institute of Technology (KTH), Stockholm, Sweden. Doctorate in biochemical engineering.

Experience and prior assignments: Several leading roles including CEO, business area manager, research manager and project manager for biopharma projects in GE Healthcare Life Sciences, Biovitrum and Pharmacia.

Board member since: 2021

Independent in relation to the company, its senior management and major shareholders.

Total holdings* in BioArctic: 3,159 class B-shares

Mikael Smedeby
Mikael Smedeby
Board member

Born: 1968

Other assignments: Lawyer and partner Advokatfirman Lindahl, Chairman of the Board of Coeli Holding AB and Sallengruppen AB (including subsidiaries). Board member of Smedeby Förvaltning AB.

Education: Master of Laws, Uppsala University, Sweden.

Experience and prior assignments: General Counsel, Structures Freemont SA. Active as a lawyer since 1994. Member of the Swedish Bar Association. Executive positions at Advokatfirman Lindahl, including Managing Partner and Chairman of the Board. Member of the Board of Directors of BioArctic, 2014–2017. Special experience in corporate law, mergers and acquisitions, financing and licensing.

Board member since: 2018

Member of Committee: Member of the Audit Committee.

Independent in relation to the company, its senior management and major shareholders.

Total holdings* in BioArctic: 37,270 Class B shares

Eugen Steiner
Eugen Steiner
Board member

Born: 1954

Other assignments: Chairman of the Board of Spago Nanomedical AB and Empros Pharma AB. Board member of A3P Biomedical AB, Epiendo Pharmaceuticals ehf, Inbox Capital AB, and Stockholm School of Entrepreneurship. Partner in HealthCap.

Education: Medical doctor, Ph.D. in clinical pharmacology at Karolinska Institutet, Stockholm, Sweden.

Experience and prior assignments: CEO or acting Chairman of the Board in several life science companies in Sweden, Norway and the US for more than 35 years.

Board member since: 2017

Member of Committee: Member of the Audit Committee and the Remuneration Committee.

Independent in relation to BioArctic, its senior management and major shareholders.

Total holdings* in BioArctic: 75,000 Class B shares

*Pertains to own holdings, related party holdings, holdings in companies and in capital insurance